Bilateral Uterine Artery Ligation During the Cesarean Delivery of Twins

Aswan University Hospital

Status: Unknown

Conditions: Cesarean Section Complications

Treatments: Drug: Oxytocin; Procedure: bilateral uterine artery ligation

Study type: Interventional

Funder types: Other

Identifiers

NCT04518176

aswu/279/8/18

Details and patient eligibility

About

Objective to assess the effectiveness of prophylactic bilateral uterine artery ligation (BUAL) in reducing the incidence of postpartum hemorrhage during cesarean delivery among women with twin pregnancy

Full description

A randomized clinical trial at Aswan University Maternity Hospital, Egypt. Women with twin pregnancy undergoing scheduled or emergency cesarean were randomized into two groups. In the BUAL group, women underwent BUAL before placental delivery; in the control group, women had cesarean delivery without BUAL. The primary outcome was the estimated blood loss during a cesarean

Enrollment: 400 estimated patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• women undergoing cesarean section
• twin pregnancy

Exclusion criteria

• Placenta previa.
• Ante-partum hemorrhage.
• patient refuse to participate

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

400 participants in 2 patient groups

study group

Experimental group

Description:

patients with twin pregnancy undergoing cesarean section underwent bilateral uterine artery ligation and received oxytocin.

Treatment:

Drug: Oxytocin

Procedure: bilateral uterine artery ligation

control group

Active Comparator group

Description:

patients with twin pregnancy undergoing cesarean section received oxytocin only.

Treatment:

Drug: Oxytocin